Abbott's multipurpose disinfecting solution for contacts gets FDA OK

ABBOTT PARK, Ill. Abbott has received market clearance from the Food and Drug Administration for RevitaLens Ocutec, a multipurpose disinfecting solution for silicone hydrogel and conventional soft contact lenses.

"This advanced, next-generation solution establishes a new standard of disinfecting technology for contact lens wearers," stated Jim Mazzo, SVP Abbott Medical Optics. "Proper contact lens care, including a rub and rinse regimen using RevitaLens Ocutec, will help patients achieve clean and comfortable lenses while enhancing overall lens-wearing satisfaction."

RevitaLens Ocutec multipurpose disinfecting solution was developed in cooperation with silicone hydrogel, microbiology and chemistry experts and with input from more than 600 eye care professionals.

It is estimated that there are 125 million contact lens wearers worldwide. Multipurpose solutions represent the majority of systems used for the care of soft contact lenses. These are comprised of a single solution for the rinsing, cleaning, disinfection and storage of lenses, and typically are composed of a preservative, buffer system and other agents to aid in lens cleaning and comfort.

Key characteristics of RevitaLens Ocutec multipurpose disinfecting solution include:

• High micro-organism kill rates;


• Removes proteins from the lens surface;


• Effectively kills acanthamoeba and fusarium;


• Reduces corneal staining; and


• Minimizes the risk of eye complications.

Abbott plans to begin retail shipment of RevitaLens Ocutec multipurpose disinfecting solution in the United States in October. The product also has CE Mark approval in Europe.